Fusion oncogenes are associated with increased metastatic capacity and persistent disease in pediatric thyroid cancers

Autor: Franco AT, Ricarte-Filho JC, Isaza A, Jones Z, Jain N, Mostoufi-Moab S, Surrey L, Laetsch TW, Li MM, DeHart JC, Reichenberger E, Taylor D, Kazahaya K, Adzick NS, Bauer AJ

Publikováno v: Yearbook of Paediatric Endocrinology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3f87bce4a89b2a7b82e4a1d1de40b925
https://doi.org/10.1530/ey.19.3.14

Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemia

Autor: Laetsch TW, Maude SL, Balduzzi A, Rives-Sola S, Bittencourt H, Boyer MW, Buechner J, De Moerloose B, Qayed M, Phillips CL, Pulsipher MA, Hiramatsu H, Tiwari R, Grupp SA

Publikováno v: Leukemia
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname

Down syndrome-associated acute lymphoblastic leukemia (DS-ALL) patients suffer risk of chemotherapy-associated toxicities and poor outcomes. We evaluated tisagenlecleucel in 16 patients with DS-ALL in two phase 2 trials (ELIANA [NCT02435849], ENSIGN

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f99e4133b9df4739ec8cf577fb709d0a
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=21392

Functional repair assay for the diagnosis of constitutional mismatch repair deficiency from non-neoplastic tissue

Autor: Shuen AY., Lanni S, Panigrahi GB, Edwards M, Yu L, Campbell BB, Mandel A, Zhang C, Zhukova N, Alharbi M, Bernstein M, Bowers DC, Carroll S, Cole KA, Constantini S, Crooks B, Dvir R, FarahR, Hijiya N, George B, Laetsch TW, Larouche V, Lindhorst S, Luiten RC, Magimairajan V, Mason G, Masn W, Mondechai O, Mushtaq N, Nocholas G, Oren M, Palma L, Pedroza LA, Ramdas J, Smauel D, Wolfe Schneider K, Seeley A, Semotiuk K, Shamvil A, Sumerauer D, Toledano H, Tomboc P, Wierman M, VAN DAMME An

Publikováno v: J Clin Oncol, no.4 (2019)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1493::181dad1a8b4b522271e2f2203098170d
https://hdl.handle.net/2078.1/212993

Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas): A Report From Children's Oncology Group.

Autor: Sargen MR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD., Barnhill RL; Department of Translational Research, Institut Curie, Unit of Formation and Research of Medicine University of Paris Cité, Paris, France., Elder DE; Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA., Swetter SM; Department of Dermatology/Pigmented Lesion and Melanoma Program, Stanford University Medical Center and Cancer Institute, Stanford, CA., Prieto VG; Departments of Anatomic Pathology and Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX., Ko JS; Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH., Bahrami A; Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA., Gerami P; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL., Karunamurthy A; Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA., Pappo AS; St Jude Children's Research Hospital, Memphis, TN., Schuchter LM; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA., LeBoit PE; Departments of Dermatology and Pathology, Helen Diller Family Cancer Center, University of California, San Francisco, San Francisco, CA., Yeh I; Departments of Dermatology and Pathology, Helen Diller Family Cancer Center, University of California, San Francisco, San Francisco, CA., Kirkwood JM; University of Pittsburgh Medical Center Hillman Cancer Center Melanoma Program, Pittsburgh, PA., Jen M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Section of Pediatric Dermatology, Children's Hospital of Philadelphia, Philadelphia, PA., Dunkel IJ; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY., Durham MM; Department of Surgery, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, GA., Christison-Lagay ER; Division of Pediatric Surgery, Yale School of Medicine, Yale New-Haven Children's Hospital, New Haven, CT., Austin MT; Division of Surgery, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX., Aldrink JH; Division of Pediatric Surgery, Department of Surgery, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, OH., Mehrhoff C; Huntsman Cancer Institute, University of Utah Hospital, Salt Lake City, UT., Hawryluk EB; Department of Dermatology, Massachusetts General Hospital, Boston, MA.; Dermatology Program, Department of Allergy and Immunology, Boston Children's Hospital, Boston, MA., Chu EY; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA., Busam KJ; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Sondak V; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL., Messina J; Department of Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL., Puig S; Melanoma Unit, Dermatology Department, Hospital Clínic de Barcelona, Instituto de Investigaciones Biomédicas August Pi i Sunye, Universitat de Barcelona, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Barcelona, Spain., Colebatch AJ; Melanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia.; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Coughlin CC; Division of Dermatology, Departments of Medicine and Pediatrics, Washington University School of Medicine in St Louis, St Louis, MO., Berrebi KG; Departments of Dermatology and Pediatrics, University of Iowa Hospitals and Clinics, Iowa City, IA., Laetsch TW; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia and Department of Pediatrics and Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Mitchell SG; Department of Pediatrics, Emory University School of Medicine, Aflac Cancer & Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA., Seynnaeve B; Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Oct 04, pp. JCO2401154. Date of Electronic Publication: 2024 Oct 04.

Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.

Autor: Laetsch TW; Children's Hospital of Philadelphia/University of Pennsylvania, Philadelphia, PA., Ludwig K; University of Texas Southwestern, Dallas, TX., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, MD., Roy-Chowdhuri S; University of Texas MD Anderson Cancer Center, Houston, TX., Patton DR; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Coffey B; Center for Biomedical Informatics and Information Technology, NCI, NIH, Bethesda, MD., Reid JM; Mayo Clinic Comprehensive Cancer Center, Rochester, MN., Piao J; Keck School of Medicine, University of Southern California, Los Angeles, CA., Saguilig L; Children's Oncology Group Statistical Center, Monrovia, CA., Alonzo TA; Keck School of Medicine, University of Southern California, Los Angeles, CA., Berg SL; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX., Mhlanga J; Washington University School of Medicine, St Louis, MO., Fox E; St Jude Children's Research Hospital, Memphis, TN., Weigel BJ; University of Minnesota, Minneapolis, MN., Hawkins DS; Seattle Children's Hospital and University of Washington, Seattle, WA., Mooney MM; Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Takebe N; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD., Parsons DW; Texas Children's Cancer and Hematology Centers, Baylor College of Medicine, Houston, TX.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2024 Sep; Vol. 8, pp. e2400258.